Search

everythinglearnresearchcommunity

for

Search:↓

Betulinic acid can help treat hepatitis C by stopping virus replication.

Tenofovir is more effective than adefovir for resistant hepatitis B, Fibroscan is good for assessing liver damage, regulatory T cells may help hepatitis C persist, and other insights into liver health and disease were found.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Promising cancer treatments were found, but the manufacturer closed.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Provenge extends prostate cancer survival by about 4 months.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

Intravenous methylprednisolone helped over half of alopecia areata patients regrow hair, but many relapsed.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

Mycophenolate mofetil is a good alternative for autoimmune hepatitis patients who can't tolerate azathioprine.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Two patients with stubborn hair loss grew hair after PDRN injections.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

Baricitinib helps regrow hair and improves quality of life and mental health in severe alopecia areata patients.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

JAK inhibitors are effective treatments for alopecia areata.